✨ Your Portfolio is fetched and updated from zerodha.
Large Pharmaceuticals

Dr. Reddy's Laboratories Ltd.

DRREDDY

Market Cap
₹1,00,256 Cr.
P/E
18.66

Dr. Reddy's Laboratories Ltd.

  • Dr. Reddy's Lab
  • Lupin
  • Mankind Pharma
  • TJI Pharma
FAQs on Dr. Reddy's Laboratories Ltd. Shareprice

Dr. Reddy's Lab has given lower returns compared to its competitors.
Dr. Reddy's Lab has grown at ~-0.37% over the last 1yrs while peers have grown at a median rate of 14.05%

Dr. Reddy's Lab is not expensive.
Latest PE of Dr. Reddy's Lab is 18.42, while 3 year average PE is 27.61.
Also latest EV/EBITDA of Dr. Reddy's Lab is 12.19 while 3yr average is 16.6.

View FAQ's On Business
Growth Table
  • Dr. Reddy's Laboratories Ltd.
  • Lupin
  • Mankind Pharma
Balance Sheet
  • Dr. Reddy's Laboratories Ltd.
  • Lupin
  • Mankind Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Dr. Reddy's Laboratories Ltd.
  • Lupin
  • Mankind Pharma
Cash Flow
  • Dr. Reddy's Laboratories Ltd.
  • Lupin
  • Mankind Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Dr. Reddy's Laboratories Ltd.
  • Lupin
  • Mankind Pharma
Quarterly Results
  • Dr. Reddy's Laboratories Ltd.
  • Lupin
  • Mankind Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Dr. Reddy's Laboratories Ltd. Financials

Balance sheet of Dr. Reddy's Lab is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Dr. Reddy's Lab is increasing.
Latest debt of Dr. Reddy's Lab is ₹2,354 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹1,453.3 Crs.

The profit is oscillating.
The profit of Dr. Reddy's Lab is ₹5,429 Crs for TTM, ₹5,578 Crs for Mar 2024 and ₹4,507 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Dr. Reddy's Lab latest dividend payout ratio is 11.96% and 3yr average dividend payout ratio is 16.54%

Companies resources are allocated to majorly unproductive assets like Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech